Best Paper Award

JPM Best Paper Award is granted annually to highlight publications of high quality, scientific significance, and extensive influence. The evaluation committee members choose 2 articles of exceptional quality that were published in the journal the year before the previous year and announce them online by the end of July.

The Prize:

– One research article and one review will be selected.
– Each winner will receive CHF 500, a certificate, and a free voucher for article processing fees valid for one year.

 
JPM Best Paper Award
 
Winner announcement: 31 July 2025

Eligibility and Requirements

– All papers published in the JPM will be eligible (both regular and Special Issue submissions).

Selection Criteria

– Scientific merit and broad impact;
– Originality of the research objectives and/or the ideas presented;
– Creativity of the study design or uniqueness of the approaches and concepts;
– Clarity of presentation;
– Citations and downloads.

 
Past Winners
 
Year: 

Winner

18 pages, 7933 KiB  
Review
Predicting the Onset of Diabetes with Machine Learning Methods
by Chun-Yang Chou, Ding-Yang Hsu and Chun-Hung Chou
J. Pers. Med. 2023, 13(3), 406; https://doi.org/10.3390/jpm13030406 - 24 Feb 2023
15 pages, 3274 KiB  
Article
Challenging ChatGPT 3.5 in Senology—An Assessment of Concordance with Breast Cancer Tumor Board Decision Making
by Sebastian Griewing, Niklas Gremke, Uwe Wagner, Michael Lingenfelder, Sebastian Kuhn and Jelena Boekhoff
J. Pers. Med. 2023, 13(10), 1502; https://doi.org/10.3390/jpm13101502 - 16 Oct 2023

Award Committee

Dr. Kenneth Pritzker Chairman

Winner

13 pages, 646 KiB  
Review
Emergency Department Overcrowding: Understanding the Factors to Find Corresponding Solutions
by Gabriele Savioli, Iride Francesca Ceresa, Nicole Gri, Gaia Bavestrello Piccini, Yaroslava Longhitano, Christian Zanza, Andrea Piccioni, Ciro Esposito, Giovanni Ricevuti and Maria Antonietta Bressan
J. Pers. Med. 2022, 12(2), 279; https://doi.org/10.3390/jpm12020279 - 14 Feb 2022
14 pages, 1499 KiB  
Article
Real-World Impact of a Pharmacogenomics-Enriched Comprehensive Medication Management Program
by Joseph P. Jarvis, Arul Prakasam Peter, Murray Keogh, Vince Baldasare, Gina M. Beanland, Zachary T. Wilkerson, Steven Kradel and Jeffrey A. Shaman
J. Pers. Med. 2022, 12(3), 421; https://doi.org/10.3390/jpm12030421 - 8 Mar 2022

Winner

Francine Durocher
1. Department of Molecular Medicine, Faculty of Medicine, Université Laval, Quebec City, QC G1T 1C2, Canada 2. Cancer Research Center, CHU de Québec-Université Laval, Quebec City, QC G1V 4G2, Canada
Zhiqiang Kevin Lu
College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA

Winner

Molecular and Cellular Mechanisms Affected in ALS
Northern Ireland Center for Stratified/Personalised Medicine, Biomedical Sciences Research Institute, Ulster University, Derry-Londonderry BT47, UK
Postulated Adjuvant Therapeutic Strategies for COVID-19
Fagron. Lichtenauerlaan 182, 3062 Rotterdam, The Netherlands
Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
CEINGE—Biotecnologie Avanzate s.c.a.r.l., 80131 Naples, Italy Department of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, 80131 Napoli, Italy Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pasca

Award Committee

Prof. Dr. Richard E. Frye Chairman
Autism Discovery and Treatment Foundation

Winner

S. Pamela K. Shiao
College of Nursing and Medical College of Georgia, Augusta University, Augusta, GA 30912, USA paper link: https://www.mdpi.com/2075-4426/8/1/10
Back to TopTop